Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Veeva SystemsVEEV -3.02%90 Debt-to-EBITDA is 0.09 as of Apr. 2026, which is 25% below its 10-year median of 0.12. GuruFocus rates VEEV with a GF Score™ of 90/100 and a GF Value™ of $290.10 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 478 Healthcare Providers & Services companies, Veeva Systems ranks better than 92.68% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Veeva Systems's Debt-to-EBITDA or its related term are showing as below:
VEEV'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.1 Med: 0.12 Max: 0.18
Current: 0.1
During the past 13 years, the highest Debt-to-EBITDA Ratio of Veeva Systems was 0.18. The lowest was 0.10. And the median was 0.12.
VEEV's Debt-to-EBITDA is ranked better than 92.68% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.215
vs VEEV: 0.10
Veeva Systems (NYSE:VEEV) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Veeva Systems Debt-to-EBITDA Related Terms
Veeva Systems Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Veeva Systems's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Veeva Systems's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Veeva Systems's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Apr. 2026) EBITDA data.
Veeva Systems (VEEV) has a Debt-to-EBITDA of 0.09 as of Apr. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Veeva Systems. This is 25% below median its historical median of 0.12. Over the past decade, Veeva Systems' Debt-to-EBITDA has ranged from 0.10 to 0.18. According to the industry distribution chart, Veeva Systems ranks #35 out of 478 companies in the Healthcare Providers & Services industry, placing it in the top 7.3%.
Is Veeva Systems' Debt-to-EBITDA too high?
Veeva Systems' current Debt-to-EBITDA of 0.09 is 25% below median its 10-year median of 0.12. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 0.18. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.22. Veeva Systems' value of 0.09 is 95.9% below this industry median. Based on the distribution chart, Veeva Systems ranks #35 out of 478 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Veeva Systems has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' Debt-to-EBITDA compare to BTSG and HQY?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #35 out of 478 companies for Debt-to-EBITDA. This places Veeva Systems in the top 7% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.22. Veeva Systems' value of 0.09 is 95.9% below this benchmark. Historically, Veeva Systems' own Debt-to-EBITDA has ranged from 0.10 to 0.18 over the past decade. While the company's 10-year median is 0.12 vs. the industry median of 2.22, Veeva Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.22, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current Debt-to-EBITDA of 0.09 is 95.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Veeva Systems. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current Debt-to-EBITDA is 0.09, which is 25% below median its own 10-year median of 0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (VEEV) is currently considered Significantly Undervalued. The stock's GF Value™ is $290.10, compared to a current price of $201.64 — trading 30.5% below its estimated fair value. The current Debt-to-EBITDA is 0.09, which is 25% below median its 10-year median of 0.12 and 95.9% below the Healthcare Providers & Services industry median of 2.22. Veeva Systems' overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Veeva Systems (VEEV), the current Debt-to-EBITDA is 0.09 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (VEEV) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of $201.64 is trading 30.5% below its estimated GF Value™ of $290.10.
GuruFocus considers Veeva Systems to be Significantly Undervalued.
Key valuation signals for VEEV:
Debt-to-EBITDA: 0.09 (25% below median its 10-year median of 0.12)
GF Value™: $290.10 vs. price of $201.64 (30.5% below fair value)
Industry Position: 95.9% below the Healthcare Providers & Services median (#35 of 478)
No single metric tells the full story. See the VEEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
90GF Score
Get the complete analysis for VEEV
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VEEV has been successfully added to your 
